Politics

Politics

Pelosi’s drug pricing plan could wipe out some key funding for low-income hospitals

By Nicholas Florko

Politics

NIH must better protect research from foreign influence, federal watchdog says

By Lev Facher

Politics

‘Why don’t you stop talking?’ Hearing on Pelosi’s drug pricing plan mired by partisan bickering

By Nicholas Florko

Politics

The Democrats shepherding Pelosi’s drug pricing bill have taken plenty of campaign cash from pharma

By Lev Facher

Politics

Trump says it’s ‘great to see’ Pelosi’s drug pricing plan

By Lev Facher and Nicholas Florko

Politics

Our 9 biggest questions about Nancy Pelosi’s drug pricing bill

By Nicholas Florko and Lev Facher

Politics

Pelosi’s drug pricing plan would let Medicare negotiate prices for up to 250 drugs

By Lev Facher

Politics

Democrats still have questions about Nancy Pelosi’s drug pricing plan

By Lev Facher

Politics

Industry groups push back against ‘troubling’ FDA crackdown on genetic tests used to predict response to drugs

By Rebecca Robbins

Politics

With ominous TV spots and a senior ‘strike force,’ AARP launches an all-out attack on pharma

By Nicholas Florko

Politics

Couple stole trade secrets from U.S. children’s hospital to market their Chinese biotech, prosecutors say

By Lev Facher

Politics

BIO’s new board chair on the industry’s bad reputation: ‘That’s ridiculous’

By Nicholas Florko

Politics

Frontrunner to lead FDA, dogged by controversies, has developed knack for confronting them

By Lev Facher and Nicholas Florko

Politics

Pelosi’s drug pricing plan is more aggressive than expected

By Nicholas Florko and Lev Facher

President Trump - New US-Mexico-Canada Trade Deal

Politics

MD Anderson oncologist met with Trump about FDA commissioner job

By Nicholas Florko

Politics

Study: A cap on Medicare drug costs helps a small few — a lot

By Nicholas Florko

Politics

As Congress considers lowering drug costs, pharma CEOs target key senators with campaign cash

By Lev Facher

Politics

Florida’s got a big plan for importing drugs from Canada. But experts warn that there are plenty of potential snags

By Nicholas Florko

Politics

Canadian officials say ‘all options’ on the table in responding to Trump importation plan

By Lev Facher

Politics

Suicide is a leading cause of death in the U.S. Here’s how Warren, Sanders, and other candidates want to help change that

By Megan Thielking

Politics

Trump has made a priority of trying to lower drug prices. But many of his most ardent supporters don’t know it

By Nicholas Florko

Politics

In bid to improve care, Trump administration to relax privacy rules for patients with history of addiction

By Lev Facher

Politics

Appealing court ruling, Trump administration renews fight to require drug prices in TV ads

By Nicholas Florko

Health

NIH will soon share genetic data with those who participated in precision medicine study

By Lev Facher

Politics

Despite their pledges, Democrats haven’t yet lowered drug prices. Here’s how they’re explaining themselves

By Nicholas Florko

‘It shows how much pharma has on their plate’: Congress just quietly passed a bill that will cost drug makers $3 billion

An unconventional health care speech: Trump wishes pharma stocks would drop, and implies drug industry is behind impeachment

White House insists drug prices are falling, but critics say its report is flawed

Trump set to nominate Stephen Hahn as FDA commissioner, pending vetting process

Pelosi’s drug pricing plan could wipe out some key funding for low-income hospitals

NIH must better protect research from foreign influence, federal watchdog says

‘Why don’t you stop talking?’ Hearing on Pelosi’s drug pricing plan mired by partisan bickering

The Democrats shepherding Pelosi’s drug pricing bill have taken plenty of campaign cash from pharma

Trump says it’s ‘great to see’ Pelosi’s drug pricing plan

Our 9 biggest questions about Nancy Pelosi’s drug pricing bill

Pelosi’s drug pricing plan would let Medicare negotiate prices for up to 250 drugs

Democrats still have questions about Nancy Pelosi’s drug pricing plan

Industry groups push back against ‘troubling’ FDA crackdown on genetic tests used to predict response to drugs

With ominous TV spots and a senior ‘strike force,’ AARP launches an all-out attack on pharma

Couple stole trade secrets from U.S. children’s hospital to market their Chinese biotech, prosecutors say

BIO’s new board chair on the industry’s bad reputation: ‘That’s ridiculous’

Frontrunner to lead FDA, dogged by controversies, has developed knack for confronting them

Pelosi’s drug pricing plan is more aggressive than expected

MD Anderson oncologist met with Trump about FDA commissioner job

Study: A cap on Medicare drug costs helps a small few — a lot

As Congress considers lowering drug costs, pharma CEOs target key senators with campaign cash

Florida’s got a big plan for importing drugs from Canada. But experts warn that there are plenty of potential snags

Canadian officials say ‘all options’ on the table in responding to Trump importation plan

Suicide is a leading cause of death in the U.S. Here’s how Warren, Sanders, and other candidates want to help change that

Trump has made a priority of trying to lower drug prices. But many of his most ardent supporters don’t know it

In bid to improve care, Trump administration to relax privacy rules for patients with history of addiction

Appealing court ruling, Trump administration renews fight to require drug prices in TV ads

NIH will soon share genetic data with those who participated in precision medicine study

Despite their pledges, Democrats haven’t yet lowered drug prices. Here’s how they’re explaining themselves